Literature DB >> 30859554

Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy.

Adam J Olszewski1,2, Anna D Chorzalska1,2,3, Annette S Kim4, Peter J Quesenberry1,2, Mary L Lopresti1,2, Mary A Fenton1,2, John L Reagan1,2, James N Butera1,2, Ilyas Sahin1,2, Celine Hamel2, Jordan Robison2, Max Petersen1,3, Patrycja M Dubielecka1,2,3.   

Abstract

Entities:  

Keywords:  chemotherapy; clonal haematopoiesis; lymphoma; next-generation sequencing; treatment-related myeloid neoplasm

Mesh：

Year:  2019        PMID： 30859554      PMCID： PMC6641995          DOI： 10.1111/bjh.15861

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   8.615


× No keyword cloud information.
  10 in total

1.  Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study.

Authors:  Nancy K Gillis; Markus Ball; Qing Zhang; Zhenjun Ma; YuLong Zhao; Sean J Yoder; Maria E Balasis; Tania E Mesa; David A Sallman; Jeffrey E Lancet; Rami S Komrokji; Alan F List; Howard L McLeod; Melissa Alsina; Rachid Baz; Kenneth H Shain; Dana E Rollison; Eric Padron
Journal:  Lancet Oncol       Date:  2016-12-04       Impact factor: 41.316

2.  Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes.

Authors:  Catherine C Coombs; Ahmet Zehir; Sean M Devlin; Ashwin Kishtagari; Aijazuddin Syed; Philip Jonsson; David M Hyman; David B Solit; Mark E Robson; José Baselga; Maria E Arcila; Marc Ladanyi; Martin S Tallman; Ross L Levine; Michael F Berger
Journal:  Cell Stem Cell       Date:  2017-08-10       Impact factor: 24.633

3.  Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.

Authors:  Christopher J Gibson; R Coleman Lindsley; Vatche Tchekmedyian; Brenton G Mar; Jiantao Shi; Siddhartha Jaiswal; Alysia Bosworth; Liton Francisco; Jianbo He; Anita Bansal; Elizabeth A Morgan; Ann S Lacasce; Arnold S Freedman; David C Fisher; Eric Jacobsen; Philippe Armand; Edwin P Alyea; John Koreth; Vincent Ho; Robert J Soiffer; Joseph H Antin; Jerome Ritz; Sarah Nikiforow; Stephen J Forman; Franziska Michor; Donna Neuberg; Ravi Bhatia; Smita Bhatia; Benjamin L Ebert
Journal:  J Clin Oncol       Date:  2017-01-09       Impact factor: 44.544

4.  Age-related clonal hematopoiesis associated with adverse outcomes.

Authors:  Siddhartha Jaiswal; Pierre Fontanillas; Jason Flannick; Alisa Manning; Peter V Grauman; Brenton G Mar; R Coleman Lindsley; Craig H Mermel; Noel Burtt; Alejandro Chavez; John M Higgins; Vladislav Moltchanov; Frank C Kuo; Michael J Kluk; Brian Henderson; Leena Kinnunen; Heikki A Koistinen; Claes Ladenvall; Gad Getz; Adolfo Correa; Benjamin F Banahan; Stacey Gabriel; Sekar Kathiresan; Heather M Stringham; Mark I McCarthy; Michael Boehnke; Jaakko Tuomilehto; Christopher Haiman; Leif Groop; Gil Atzmon; James G Wilson; Donna Neuberg; David Altshuler; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2014-11-26       Impact factor: 91.245

5.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.

Authors:  Giulio Genovese; Anna K Kähler; Robert E Handsaker; Johan Lindberg; Samuel A Rose; Samuel F Bakhoum; Kimberly Chambert; Eran Mick; Benjamin M Neale; Menachem Fromer; Shaun M Purcell; Oscar Svantesson; Mikael Landén; Martin Höglund; Sören Lehmann; Stacey B Gabriel; Jennifer L Moran; Eric S Lander; Patrick F Sullivan; Pamela Sklar; Henrik Grönberg; Christina M Hultman; Steven A McCarroll
Journal:  N Engl J Med       Date:  2014-11-26       Impact factor: 91.245

6.  Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.

Authors:  Michael J Kluk; R Coleman Lindsley; Jon C Aster; Neal I Lindeman; David Szeto; Dimity Hall; Frank C Kuo
Journal:  J Mol Diagn       Date:  2016-07       Impact factor: 5.568

7.  Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens.

Authors:  Eric A Severson; Gregory M Riedlinger; Caitlin F Connelly; Jo-Anne Vergilio; Mendel Goldfinger; Shakti Ramkissoon; Garrett M Frampton; Jeffrey S Ross; Anthony Fratella-Calabrese; Laurie Gay; Siraj Ali; Vincent Miller; Julia Elvin; Mohammad Hadigol; Kim M Hirshfield; Lorna Rodriguez-Rodriguez; Shridar Ganesan; Hossein Khiabanian
Journal:  Blood       Date:  2018-04-20       Impact factor: 25.476

8.  Age-related mutations associated with clonal hematopoietic expansion and malignancies.

Authors:  Mingchao Xie; Charles Lu; Jiayin Wang; Michael D McLellan; Kimberly J Johnson; Michael C Wendl; Joshua F McMichael; Heather K Schmidt; Venkata Yellapantula; Christopher A Miller; Bradley A Ozenberger; John S Welch; Daniel C Link; Matthew J Walter; Elaine R Mardis; John F Dipersio; Feng Chen; Richard K Wilson; Timothy J Ley; Li Ding
Journal:  Nat Med       Date:  2014-10-19       Impact factor: 53.440

9.  Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.

Authors:  Koichi Takahashi; Feng Wang; Hagop Kantarjian; Denaha Doss; Kanhav Khanna; Erika Thompson; Li Zhao; Keyur Patel; Sattva Neelapu; Curtis Gumbs; Carlos Bueso-Ramos; Courtney D DiNardo; Simona Colla; Farhad Ravandi; Jianhua Zhang; Xuelin Huang; Xifeng Wu; Felipe Samaniego; Guillermo Garcia-Manero; P Andrew Futreal
Journal:  Lancet Oncol       Date:  2016-12-03       Impact factor: 41.316

10.  Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults.

Authors:  Andrew L Young; Grant A Challen; Brenda M Birmann; Todd E Druley
Journal:  Nat Commun       Date:  2016-08-22       Impact factor: 14.919
  10 in total
  5 in total

1.  Exposure to ibritumomab tiuxetan and incidence of treatment-related myeloid neoplasms among older patients with B-cell lymphoma: a population-based study.

Authors:  Mengyang Di; Thomas A Ollila; Adam J Olszewski
Journal:  Leukemia       Date:  2020-03-17       Impact factor: 11.528

Review 2.  Clonal hematopoiesis: Mutation-specific adaptation to environmental change.

Authors:  Marcus A Florez; Brandon T Tran; Trisha K Wathan; James DeGregori; Eric M Pietras; Katherine Y King
Journal:  Cell Stem Cell       Date:  2022-06-02       Impact factor: 25.269

Review 3.  Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.

Authors:  Yammy Yung; Emily Lee; Hiu-Tung Chu; Pui-Kwan Yip; Harinder Gill
Journal:  Int J Mol Sci       Date:  2021-01-11       Impact factor: 5.923

Review 4.  Liquid biopsies in pediatric oncology: opportunities and obstacles.

Authors:  R Taylor Sundby; Alex Pan; Jack F Shern
Journal:  Curr Opin Pediatr       Date:  2022-02-01       Impact factor: 2.893

Review 5.  Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential in Hematology and Cardiovascular Disease.

Authors:  Gregor Hoermann
Journal:  Diagnostics (Basel)       Date:  2022-07-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.